| Literature DB >> 33880862 |
Maria L Corrado1, Tanja Knaus1, Francesco G Mutti1.
Abstract
We present a one-pot cascade for the synthesis of phenylpropanolamines (PPAs) in high optical purities (er and dr up to >99.5 %) and analytical yields (up to 95 %) by using 1-phenylpropane-1,2-diols as key intermediates. This bioamination entails the combination of an alcohol dehydrogenase (ADH), an ω-transaminase (ωTA) and an alanine dehydrogenase to create a redox-neutral network, which harnesses the exquisite and complementary regio- and stereo-selectivities of the selected ADHs and ωTAs. The requisite 1-phenylpropane-1,2-diol intermediates were obtained from trans- or cis-β-methylstyrene by combining a styrene monooxygenase with epoxide hydrolases. Furthermore, in selected cases, the envisioned cascade enabled to obtain the structural isomer (1S,2R)-1-amino-1-phenylpropan-2-ol in high optical purity (er and dr >99.5 %). This is the first report on an enzymatic method that enables to obtain all of the four possible PPA stereoisomers in great enantio- and diastereo-selectivity.Entities:
Keywords: Biocatalysis; alcohol dehydrogenases; biocatalytic cascades; chiral amino alcohols; ω-transaminases
Mesh:
Substances:
Year: 2021 PMID: 33880862 PMCID: PMC8359840 DOI: 10.1002/cbic.202100123
Source DB: PubMed Journal: Chembiochem ISSN: 1439-4227 Impact factor: 3.164
Scheme 1One‐pot enzymatic cascades for the synthesis of optically active phenylpropanolamines. Previous work: a) conversion of benzaldehyde and pyruvate preferably in sequential steps since a concurrent procedure produces ca. 25 % of benzylamine as byproduct; b) conversion of 1‐phenylpropane‐1,2‐dione in sequential steps comprising de‐activation of ωTA after step 1 to avoid formation of 1‐phenylpropane‐1,2‐diols as by‐products; c) conversion of trans‐ or cis‐β‐methylstyrene into 1‐phenylpropane‐1,2‐diols followed by biocatalytic hydride‐borrowing amination using an ADH and an AmDH. This work: d) conversion of 1‐phenylpropane‐1,2‐diols (obtained as in strategy c, step 1) followed by redox‐neutral amination using an ADH, an ωTA and an AlaDH.
Scheme 2Possible pathways and products for the one‐pot multi‐enzyme cascade.
Overview of best ADH/ωTA/AlaDH combinations in the one‐pot cascade reaction for the conversion of chiral diols 3 to either optically active 5 or 5′.
|
Entry |
Substrate |
ADH |
ωTA |
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
1 |
(1 |
Bs‐BDHA |
Cv( |
86±3 |
>99.5 : <0.5 ( |
96 : 4 [ |
n.d. |
n.a. |
n.a. |
|
2 |
(1 |
Bs‐BDHA |
Bm( |
88±1 |
>99.5 : <0.5 ( |
96 : 4 [ |
n.d. |
n.a. |
n.a. |
|
3 |
(1 |
Ls‐ADH |
Cv( |
76±<1 |
>99.5 : <0.5 ( |
>99.5 : <0.5 [ |
n.d. |
n.a. |
n.a. |
|
4 |
(1 |
Ls‐ADH |
Bm( |
81±<1 |
>99.5 : <0.5 ( |
96 : 2/2 [ |
n.d. |
n.a. |
n.a. |
|
5 |
(1 |
Bs‐BDHA |
At( |
95±2 |
>99.5 : <0.5 ( |
98 : 2 [ |
n.d. |
n.a. |
n.a. |
|
6 |
(1 |
Bs‐BDHA |
As( |
92±<1 |
>99.5 : <0.5 ( |
97 : 3 [ |
n.d. |
n.a. |
n.a. |
|
7 |
(1 |
Aa‐ADH |
At( |
96±<1 |
99 : 1 ( |
98 : 2 [ |
n.d. |
n.a. |
n.a. |
|
8 |
(1 |
Aa‐ADH |
As( |
90±1 |
99 : 1 ( |
96 : 4 [ |
n.d. |
n.a. |
n.a. |
|
9 |
(1 |
Ls‐ADH |
At( |
95±<1 |
>99.5 : <0.5 ( |
>99.5 : <0.5 [ |
n.d. |
n.a. |
n.a. |
|
10 |
(1 |
Ls‐ADH |
As( |
90±<1 |
>99.5 : <0.5 ( |
>99.5 : <0.5 [ |
n.d. |
n.a. |
n.a. |
|
11 |
(1 |
Aa‐ADH |
At( |
21±<1 |
>99.5 : <0.5 ( |
>99.5 : <0.5 [ |
58±1 |
>99.5 : <0.5 [ |
95 : 5 [ |
|
12 |
(1 |
Aa‐ADH |
As( |
16±<1 |
>99.5 : <0.5 ( |
>99.5 : <0.5 [ |
61±<1 |
>99.5 : <0.5 [ |
>99.5 : <0.5 [ |
n.d.=not detected; n.a.=not applicable. [a] Determined by RP‐HPLC analysis, after derivatization with GITC (only observed isomers were reported). [b] 15 mM. [c] 20 mM. [d] 10 mM. The reported values represent the average of two samples.
Multi‐enzyme conversion of trans‐ and cis‐1 into (1S,2S)‐5 and (1R,2S)‐5 through two consecutive one‐pot transformations.
|
Entry |
Sub. |
Step 1 yield [%] |
Step 2 yield [%] |
Combined yield [%] |
|
|
|---|---|---|---|---|---|---|
|
1 |
|
86 |
83 |
71 |
>99.5 : <0.5 (1 |
97 : 3[a] |
|
2 |
|
70 |
75 |
53 |
>99.5 : <0.5 (1 |
>99.5 : <0.5 |
[a] Dependent on stereoselectivity of Step 1.